IRWD
Ironwood Pharmaceuticals IncCompany with tickers: IRWD
CIK
1446847
CUSIP
46333X108
Shares Outstanding
164,613,406
Website
https://www.ironwoodpharma.com
Investor Relations
https://investor.ironwoodpharma.com/home/default.aspx
13F Activity (30d)
3 filings
2 filers
Share-repurchase activity from the company's own XBRL filings — cash spent buying back common stock per fiscal year and per recent quarter, share counts where the company tagged them, and the buyback program's authorization — paired with the company's at-the-market (ATM) equity offering programs, the dilution side of the same picture. Repurchase amounts come exclusively from tagged SEC data; program figures with no tagged equivalent (untagged authorizations and all ATM figures) are read from the filing's own text and shown only after verification.
Program Authorized
$150,000,000
as of 2021-05-31
· not restated in filings since 2025-03-31
Remaining Authorization
$32,400,000
as of 2022-03-31
· not restated in filings since 2022-05-05
Program Utilization
78.4%
$117,600,000 used of $150,000,000
Cash spent on buybacks by quarter
Cash deployed each quarter. Δ marks quarters derived from the company's cumulative year-to-date disclosures.
Repurchase History
| Fiscal Year Ended | Cash Spent | Source |
|---|---|---|
| 2022-12-31 | $126,394,000 | 10-K, filed 2025-03-31 |
| 2021-12-31 | $24,131,000 | 10-K, filed 2024-02-16 |